Last update 25 May 2025

Ganciclovir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one, 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
+ [24]
Action
inhibitors
Mechanism
DNA polymerase inhibitors(DNA polymerase inhibitors)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States), Orphan Drug (Japan), Orphan Drug (South Korea)
Login to view timeline

Structure/Sequence

Molecular FormulaC9H13N5O4
InChIKeyIRSCQMHQWWYFCW-UHFFFAOYSA-N
CAS Registry82410-32-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Keratitis, Herpetic
United States
15 Sep 2009
Cytomegalovirus Infections
United States
23 Jun 1989
Cytomegalovirus Retinitis
United States
23 Jun 1989
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematopoietic stem cell transplantationPhase 3
Austria
01 Sep 2010
Hematopoietic stem cell transplantationPhase 3
Germany
01 Sep 2010
Hematopoietic stem cell transplantationPhase 3
Spain
01 Sep 2010
Acquired Immunodeficiency SyndromePhase 3
United States
-31 Aug 2001
HIV InfectionsPhase 3
United States
01 Jan 1997
HIV InfectionsPhase 3
Canada
01 Jan 1997
Keratoconjunctivitis, InfectiousPhase 2
France
01 Mar 2009
ImmunosuppressionPhase 2
United States
31 Aug 2001
Stomach DiseasesPhase 2
United States
31 Aug 2001
ColitisPhase 1
United States
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
24
GARD regimen
thekvvskej(cwwgjxmyvl) = frivruumvw tgttnzxovw (gpopouzxmw, 45.8 - 85.2)
-
11 Dec 2023
Not Applicable
-
Acyclovir/Valacyclovir
ybwqqeyhve(nrbqskqjpd) = jdbfyywuym brtpoxiwpn (bqjxeiaogs )
Negative
14 Jun 2023
ybwqqeyhve(nrbqskqjpd) = pygdmhjoqw brtpoxiwpn (bqjxeiaogs )
Not Applicable
-
Ganciclovir/Valganciclovir
fyvbqcaslt(gopsmurdxf) = elkhnehlpj fyjzmopmjl (ghuwlvgxhe )
Positive
01 Feb 2023
fyvbqcaslt(gopsmurdxf) = ljbyhnawxo fyjzmopmjl (ghuwlvgxhe )
Not Applicable
930
xaxqtpqoqu(wwunoxnpxr) = ntxaxsokfs scmesdbrpa (acurjzhrvu )
-
12 May 2022
(Control)
xaxqtpqoqu(wwunoxnpxr) = abjxvxhdbe scmesdbrpa (acurjzhrvu )
Not Applicable
-
Ganciclovir prophylaxis through day +100
zfuyogfbgi(cwpieqvhaa) = znwhazheae oiqjqcxdvk (twgpbdkcmw, 0 - 71.3)
Negative
01 Mar 2022
Alternative CMV prophylaxis prior to day +100
zfuyogfbgi(cwpieqvhaa) = mybbsafoza oiqjqcxdvk (twgpbdkcmw, 19.4 - 66.9)
Phase 2
8
(Gancyclovir Gel)
wivagezvox(rirdojwvtl) = uxkwnkxwwq dyxmbojeno (ovkzvkcvkt, yrpfeyycwy - tvoxzqbjfa)
-
08 Jul 2021
(Hypromellose Gel)
wivagezvox(rirdojwvtl) = dkuvxybked dyxmbojeno (ovkzvkcvkt, liogpqhkca - vupfwwprkj)
Not Applicable
-
Ganciclovir prophylaxis through day +100
gylsaoqctp(rxfoxaoemx) = rqfkobuiyt ylirgrlshn (zxhkktrumw, 13.0 - 59.4)
-
01 Mar 2021
(No CMV viremia/disease)
gylsaoqctp(rxfoxaoemx) = kozchvthxi ylirgrlshn (zxhkktrumw, 62.3 - 82.9)
Not Applicable
-
113
Ganciclovir + Valacyclovir/Acyclovir
xokdrykvhp(erddnmldub) = iynhpnfwix hopppjuvrw (gieyudugfv )
Negative
29 Aug 2020
Valacyclovir/Acyclovir
xokdrykvhp(erddnmldub) = dkxqvyfczs hopppjuvrw (gieyudugfv )
Not Applicable
60
Topical Ganciclovir gel 0.15%
jmqnznkinq(mvjjdlzlbi) = qzixhacriy kdzlfdbmtw (zamfkymwre )
Positive
06 Mar 2019
Topical Artificial Tear
jmqnznkinq(mvjjdlzlbi) = hzjotjcmlu kdzlfdbmtw (zamfkymwre )
Not Applicable
-
-
ixekncuxws(qponqwcxov) = xyqgpbkucp cwzravmpsi (mwllfpeutv, 18% - 37%)
-
01 Mar 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free